Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia : between bench and bedside
Cabrera-Fuentes, H. A (Escuela de Ingeniería y Ciencias, Centro de Biotecnología-FEMSA, Tecnológico de Monterrey)
Alba-Alba, Corina (Institute of Genetics, Univeristy of the Sea. Puerto Escondido Campus, Oaxaca Oaxacan System of State Universities (SUNEO))
Aragones, Julian (Instituto de Investigación Hospital Universitario de la Princesa)
Bernhagen, Jürgen (Institute of Biochemistry and Molecular Cell Biology, RWTH Aachen University)
Boisvert, William A. (Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii)
Bøtker, Hans Erik (Aarhus University Hospital (Aarhus, Dinamarca))
Cesarman-Maus, Gabriela (Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico)
Fleming, Ingrid (Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe-University, Frankfurt, Germany)
García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Lecour, Sandrine (Hatter Institute and MRC Inter-University Cape Heart Unit, Faculty of Health Sciences, University of Cape Town)
Liehn, Elisa (Institute for Molecular Cardiovascular Research, RWTH University Hospital Aachen)
Marber, Michael S. (King's College London)
Marina, Nephtali (Department of Clinical Pharmacology, University College London)
Mayr, Manuel (King's College London. The James Black Centre)
Perez-Mendez, Oscar (Department of Molecular Biology, National Institute of Cardiology, Mexico City)
Miura, Tetsuji (Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine)
Ruiz-Meana, Marisol (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Salinas-Estefanon, Eduardo M. (Laboratorio de Biofísica Cardiaca, Instituto de Fisiología, Universidad Autónoma de Puebla, Puebla, Mexico)
Ong, Sang-Bing (National Heart Research Institute Singapore, National Heart Centre Singapore)
Schnittler, Hans J. (Institute of Anatomy and Vascular Biology, Westfalian-Wilhelms-University, Münster)
Sanchez-Vega, Jose T. (Universidad Nacional Autónoma de México. Departamento de Microbiología y Parasitología)
Sumoza-Toledo, Adriana (Laboratorio Multidisciplinario de Ciencias Biomédicas, Instituto de Investigaciones Medico-Biológicas, Universidad Veracruzana campus Veracruz)
Vogel, Carl-Wilhelm (Department of Pathology, John A. Burns School of Medicine, University of Hawaii)
Yarullina, Dina (Department of Microbiology, Kazan Federal University, Kazan, Russian Federation)
Yellon, Derek M. (The National Institute of Health Research University College London Hospitals Biomedical Research Centre)
Preissner, Klaus T. (Institute of Biochemistry, Medical School, Justus-Liebig University, Giessen, Germany)
Hausenloy, Derek J. (The National Institute of Health Research University College London Hospitals Biomedical Research Centre)
Universitat Autònoma de Barcelona

Data:	2015
Resum:	Recent advances in basic cardiovascular research as well as their translation into the clinical situation were the focus at the last "New Frontiers in Cardiovascular Research meeting". Major topics included the characterization of new targets and procedures in cardioprotection, deciphering new players and inflammatory mechanisms in ischemic heart disease as well as uncovering microRNAs and other biomarkers as versatile and possibly causal factors in cardiovascular pathogenesis. Although a number of pathological situations such as ischemia-reperfusion injury or atherosclerosis can be simulated and manipulated in diverse animal models, also to challenge new drugs for intervention, patient studies are the ultimate litmus test to obtain unequivocal information about the validity of biomedical concepts and their application in the clinics. Thus, the open and bidirectional exchange between bench and bedside is crucial to advance the field of ischemic heart disease with a particular emphasis of understanding long-lasting approaches in cardioprotection.
Ajuts:	Ministerio de Economía y Competitividad SAF2013-46058-R Ministerio de Economía y Competitividad RD12/0042/0065 Ministerio de Economía y Competitividad PI14/01413 Ministerio de Economía y Competitividad RD12/0042/0021 Ministerio de Economía y Competitividad PI15/01655 Ministerio de Economía y Competitividad PI12/00788
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Atherosclerosis ; Cardioprotection ; Cardiovascular disease ; Endothelial permeability ; Extracellular RNA ; High-density lipoprotein ; Hypoxia ; Inflammation ; Ischemia/reperfusion injury ; Macrophage polarization ; MicroRNAs ; Mitochondria ; Platelet dysfunction ; Vascular biology
Publicat a:	Basic Research in Cardiology, Vol. 111 (december 2015) , ISSN 1435-1803

DOI: 10.1007/s00395-015-0527-0
PMID: 26667317
PMID: 26667317

13 p, 508.4 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats